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TO THE EDITOR
The causative agent of Lyme disease,
Borrelia burgdorferi, is a spirochete
parasitizing vertebrates and transmitted
by the tick, Ixodes sp. Lyme disease is
the most common vector-borne disease
in the Northern Hemisphere (Piesman
and Gern, 2004). It manifests itself
frequently with an erythema migrans
rash at the site of the infection. How-
ever, the infection can progress and
disseminate, affecting other skin sites,
the joints, the heart, and the nervous
system in humans. Control of the initial
cutaneous phase may play a crucial
role in the outcome of the disease, as
not all patients develop disseminated
clinical infection (Steere and Glick-
stein, 2004).
The skin constitutes a complex
physical barrier. First, the epidermis
comprises mainly keratinocytes (KCs)
and Langerhans cells. These cells pos-
sess specific Toll-like receptors (TLRs)
that recognize certain defined patterns,
the pathogen-associated molecular pat-
terns, present on pathogens. The inter-
action between pathogen-associated
molecular patterns and TLRs leads to
the activation of the NF-kB pathway,
with the production of inflammatory
molecules including chemokines, cyto-
kines, and antimicrobial peptides
(AMPs) (Pivarcsi et al., 2004). These
molecules of innate immunity are
essential to the control of infection.
Dermal fibroblasts (FBs) constitute a
second group of resident skin cells that
secrete the extracellular matrix and
communicate with other cell types such
as dermal dendritic cells, mast cells,
macrophages, and KCs (Sorrell and
Caplan, 2004).
Ebnet et al. (1997) reported the
activation of NF-kB upon the inter-
action of Borrelia with human KCs and
FBs. However, no recent study has
investigated the potential induction of
AMPs in the interaction of B. burgdor-
feri with resident skin cells. We studied
the induction of the proinflammatory
molecule IL-8, defensins, and catheli-
cidin. IL-8 is a chemokine that attracts
neutrophils, major cells involved in
inflammation and secreting AMPs. De-
fensins are produced by leukocytes and
various epithelial cells (Ganz, 2003).
The cathelicidin LL-37, in humans, is
present constitutively in neutrophil
granules and is inducible in epithelial
cells in response to infection. Their role
in the control of several skin inflamma-
tions is well established (Nizet et al.,
2001; Ong et al., 2002; Braff et al.,
2005). We used ELISA to measure the
secretion of IL-8 and HBD-2 (human b-
defensin-2) and quantitative real-time
reverse transcriptase-PCR to study the
induction of HBD-2 and LL-37 mRNAs
by KCs and FBs. IL-8 was induced by B.
burgdorferi in a dose-dependent man-
ner in KCs and FBs (Figure 1a and b).
Regarding AMP mRNAs, defensin, but
not cathelicidin, was induced in KCs
(Figure 1c and f). In FBs, Borrelia did
not induce HBD-2 and a weak expres-
sion of LL-37 mRNA was observed
(Figure 1d and f). A kinetic study
revealed that IL-8 secretion reached its
highest level at 12 hours for both KCs
and FBs (Figure 1g and h), whereas
HBD-2 mRNA reached a peak at
6 hours in KCs (Figure 1i), also con-
firmed by the measure of HBD-2
secretion by ELISA (data not shown).
Only very weak amounts were found to
be secreted by FBs upon stimulation
with Borrelia (Figure 1j). For LL-37
mRNA, only marginal expression by
KCs was shown (Figure 1k), whereas
Borrelia elicited a much higher expres-
sion in FBs, which peaked at 6 hours
(Figure 1l). As Borrelia are transmitted
by the Ixodes tick, we analyzed the
effect of tick salivary gland (SG) extract
on host cell inflammation. As can be
seen in Figure 2, induction of IL-8 and
HBD-2 was significantly inhibited by
SG extract. The inhibitory effect on IL-8
Abbreviations: AMP, antimicrobial peptide; FB, fibroblast; HBD, human b-defensin; KC, keratinocyte;
SG, salivary gland; TLR, Toll-like receptor
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Figure 1. The co-incubation of resident skin cells with B. burgdorferi N40 induces an inflammatory response. (A) Dose–response of human primary
keratinocytes (KCs) and fibroblasts (FBs) stimulated with various concentrations of B. burgdorferi N40 for 24 hours. IL-8 (a, b), human b-defensin-2 (HBD-2)
mRNA (c, d), and LL-37 mRNA (e, f) were measured as selected markers of inflammation. KCs and FBs were incubated with 100 Borrelia, 10 Borrelia, and 1
Borrelia per cell, negative control: KCs and FBs with medium alone (ø). IL-1-b was the positive control for HBD-2, and IGF-I was the positive control for LL-37.
(B) Kinetic study of the inflammatory response of KCs and FBs: measure of IL-8 secretion by ELISA (g, h), measure of HBD-2 (i, j) and LL-37 mRNA expression
(k, l) by quantitative real-time reverse transcriptase-PCR. Cells were incubated with B. burgdorferi (100 to 1 cell) for various times. Negative control was
unstimulated cells (ø). Each bar shows the mean±SD from three separate experiments. ***Po0.001; **Po0.01; and *Po0.05 compared between stimulated
and non-stimulated cells.
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Figure 2. Tick salivary gland extract exerts an inhibitory effect on the interaction of human primary keratinocytes with B. burgdorferi N40 at 6 and
24hours. Two cell–bacteria ratios were tested: 100 Borrelia (100 Bb) to 1 cell and 10 Borrelia to 1 cell (10 Bb). Measure of the inhibition of IL-8 (a, b) and
human b-defensin-2 (HBD-2) (c, d) secretions by ELISA. ø: negative control and IL-1b: positive control. The data are representative of three independent
experiments with ±SD. ***Po0.001; **Po0.01; and *Po0.05 compared with control cells.
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and HBD-2 secretions was seen as early
as 6 hours after the incubation of SG
extracts (Figure 2a–c) and was most
remarkable after 24 hours of incubation
(Figure 2 b–d).
The skin is the first organ to be
infected by Borrelia, and innate resis-
tance may be particularly important in
limiting spirochetal dissemination. IL-8
and defensin secretion by these resident
cells makes KCs important actors in the
play of innate cutaneous immunity in
the early phase of Lyme disease. They
interact in the epidermis with Langerhans
cells, secreting significant amounts of
IL-1b, and also with FBs by secreting
IL-1b and TGF-b (Werner et al., 2007).
The tick feeds for 24–48 hours before
inoculating the organism into the skin
(Fikrig and Narasimhan, 2006). Many
studies have shown the immunomodu-
latory properties of tick saliva on
adaptive immunity, but only a few
studies have reported its effect on
innate immunity (Brossard and Wikel,
2004, Hovius et al., 2007). The surface
lipoproteins of Borrelia interact with
TLR2 (Hirschfeld et al., 1999), present
on KCs (Pivarcsi et al., 2004). Recently,
it was postulated that in the early phase
of Borrelia transmission, a protein of
tick saliva, Salp15, could help the
bacteria to evade the host immune
response by binding to OspC, inhibiting
antibody-mediated killing (Rama-
moorthi et al., 2005); to the CD4 T-cell
receptor (Garg et al., 2006); and to the
DC-SIGN receptor of dendritic cells
(Hovius et al., 2008). SG extract could
also exert its effect by inhibiting the
interaction between TLR and Osp anti-
gens (Fikrig and Narasimhan, 2006).
Preliminary data support this hypoth-
esis: OspC, a TLR2 ligand, preincu-
bated with Salp15 inhibits KC
inflammation (data not shown). AMPs
have been described as multifunctional
molecules—they have antimicrobial
activities but also chemotactic proper-
ties on immune cells (Yang et al., 2002;
Schro¨der and Harder, 2006). LL-37 and
a-defensin isolated from neutrophil
granules can affect the survival of
Borrelia in vitro (Lusitani et al., 2002).
We also observed such an effect of
HBD-2 and LL-37 on Borrelia in vitro,
but the effect was transient, as the
bacteria recovered after 24 hours (data
not shown). Tick saliva would inhibit
defensin and chemokines not as AMP
molecules but as chemotactic mole-
cules, active on immune cells. This
local inhibition of cellular infiltrate
could allow Borrelia to multiply locally
before disseminating to the rest of the
body. The cutaneous inflammation
constitutes the initial phase of Lyme
disease, and the innate immune re-
sponse could be essential to controlling
the development of the disease. At this
point, it is interesting to point out that
tick saliva exerts its effects directly on
the antichemotactic and antibacterial
arms of the immune response as well as
by skewing the immune response to a
less harmful antibacterial response.
During natural transmission, Borrelia
may benefit from these two tick-saliva-
induced complementary mechanisms
to escape the immune system.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank C Dezutter, from EA 3732, University
Lyon I, France, for her scientific support in human
primary KC culture, and B Betschart and L Gern,
University of Neuchaˆtel, for their help in main-
taining the tick colony. This research was sup-
ported in part by a grant from the School of
Medicine of Strasbourg. Claire Marchal was
supported by grant 07/908/225 from the Conseil
Regional d’Alsace.
Claire MP Marchal1, Benjamin J. Luft2,
Xiaohua Yang2, Jean Sibilia1, Benoıˆt
Jaulhac1,3 and Nathalie M Boulanger1,3
1UPRES EA 3432, Physiopathologie des
interactions hoˆtes-bacte´ries, Faculte´s de
Me´decine et de Pharmacie, Universite´ Louis
Pasteur, Strasbourg, France and 2Division of
Infectious Diseases, Stony Brook University,
Stony Brook, New York, USA
E-mail: nathalie.boulanger@pharma.u-strasbg.fr
3BJ and NB contributed equally to the paper
REFERENCES
Braff MH, Zaiou M, Fierer J, Nizet V, Gallo RL
(2005) Keratinocyte production of cathelici-
din provides direct activity against bacterial
skin pathogens. Infect Immun 73:6771–81
Brossard M, Wikel SK (2004) Tick immunobiol-
ogy. Parasitology 129:161–76
Ebnet K, Brown KD, Siebenlist UK, Simon MM,
Shaw S (1997) Borrelia burgdorferi activates
nuclear factor-kappa B and is a potent
inducer of chemokine and adhesion mole-
cule gene expression in endothelial cells and
fibroblasts. J Immunol 158:3285–92
Fikrig E, Narasimhan S (2006) Borrelia burgdor-
feri-traveling incognito? Microbes Infect
8:1390–9
Ganz T (2003) Defensins: antimicrobial peptides
of innate immunity. Nat Rev Immunol
3:710–20
Garg R, Juncadella IJ, Ramamoorthi N, Ashish,
Ananthanarayanan SK, Thomas V et al.
(2006) Cutting edge: CD4 is the receptor for
the tick saliva immunosuppressor, Salp15.
J Immunol 177:6579–83
Hirschfeld M, Kirschning CJ, Schwandner R,
Wesche H, Weis JH, Wooten RM et al.
(1999) Cutting edge: inflammatory signaling
by Borrelia burgdorferi lipoproteins is
mediated by toll-like receptor 2. J Immunol
163:2382–6
Hovius JW, de Jong MA, den Dunnen J, Litjens M,
Fikrig E, van der Poll T et al. (2008) Salp15
binding to DC-SIGN inhibits cytokine ex-
pression by impairing both nucleosome
remodeling and mRNA stabilization. PLoS
Pathog 4:e31
Hovius JW, van Dam AP, Fikrig E (2007) Tick-
host-pathogen interactions in Lyme borrelio-
sis. Trends Parasitol 23:434–8
Lusitani D, Malawista SE, Montgomery RR (2002)
Borrelia burgdorferi are susceptible to killing
by a variety of human polymorphonuclear
leukocyte components. J Infect Dis
185:797–804
Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill
J, Dorschner RA et al. (2001) Innate anti-
microbial peptide protects the skin from
invasive bacterial infection. Nature
414:454–7
Ong PY, Ohtake T, Brandt C, Strickland I,
Boguniewicz M, Ganz T et al. (2002)
Endogenous antimicrobial peptides and skin
infections in atopic dermatitis. N Engl J Med
347:1151–60
Piesman J, Gern L (2004) Lyme borreliosis in
Europe and North America. Parasitology
129(Suppl):S191–220
Pivarcsi A, Kemeny L, Dobozy A (2004)
Innate immune functions of the keratino-
cytes. Acta Microbiol Immunol Hung
51:303–10
Ramamoorthi N, Narasimhan S, Pal U, Bao F,
Yang XF, Fish D et al. (2005) The
Lyme disease agent exploits a tick protein
to infect the mammalian host. Nature
436:573–7
Schro¨der JM, Harder J (2006) Antimicrobial skin
peptides and proteins. J Cell Mol Life Sci
63:469–86
Sorrell JM, Caplan AI (2004) Fibroblast hetero-
geneity: more than skin deep. J Cell Sci
117:667–75
Steere AC, Glickstein L (2004) Elucidation of Lyme
arthritis. Nat Rev Immunol 4:143–52
Werner S, Krieg T, Smola H (2007) Keratinocyte-
fibroblast interactions in wound healing.
J Invest Dermatol 127:998–1008
Yang D, Biragyn A, Kwak LW, Oppenheim JJ
(2002) Mammalian defensins: more
than just microbicidal. Trends Immunol
23:291–5
www.jidonline.org 2517
C Marchal et al.
Suppression of Defensin by Tick Salivary Gland Extract
